Reuters logo
BRIEF-Global Blood Therapeutics posts Q3 loss per share $0.66
November 2, 2017 / 9:11 PM / 22 days ago

BRIEF-Global Blood Therapeutics posts Q3 loss per share $0.66

Nov 2 (Reuters) - Global Blood Therapeutics Inc

* Global Blood Therapeutics reports recent business progress and provides third quarter 2017 financial results

* Q3 loss per share $0.66

* Q3 earnings per share view $-0.61 -- Thomson Reuters I/B/E/S

* Global Blood Therapeutics - continue to expect cash,cash equivalents,marketable securities to be enough to take co to top-line data in hope study​

* Global Blood Therapeutics Inc - ‍qtrly cash, cash equivalents, marketable securities $259.4 million at Sept 30, 2017 versus $197.3 million at Dec 31, 2016​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below